Moderna’s COVID-19 vaccine has gotten the Food and Drug Administration (FDA) full approval according to the health company. This means it now has a full license for administering to patients.
Previously Moderna’s COVID-19 vaccine only had approval for use in cases of emergencies during the heat of the coronavirus in 2020. After a whole year of vigorous testing and clinical trial data from about 30,000 people shows the vaccine is safe and effective.
Moderna’s CEO Stéphane Bancel describes the approval as “….a momentous milestone in Moderna’s history.” The vaccine can now be advertised directly to patients; interestingly it is Moderna’s first FDA-approved product in the US.
The company now joins Pfizer to begin the trial of its Omicron-specific COVID-19 vaccine. This vaccine shot development is a result of its original two-dose shots that didn’t fully protect against the Omicron virus. The vaccine in the trial is the new mRNA-1273.529 product.
The Omicron variant of the Coronavirus is an advanced mutation of the present COVID-19 virus spreading globally. It has been able to block the antibodies the human body produced as a result of the first two doses.
Read Also:
– Pfizer Is Testing Its Omicron Specific COVID-19 Vaccine For Effectiveness
– CES 2022: Growing Covid-19 Presence Make OEM Withdraw Physically
– E3 Announces Its 2022 Event Will Be Entirely Online Due To Coronavirus
Research has shown the third shot, usually called the booster has been able to neutralise the virus but only for six months. Hence the need for a fourth shot which hopefully will completely neutralise the threat. Altogether, 600 people will be trialling the Omicron-specific COVID-19 vaccine of Moderna. Moderna’s vaccine has been the most effective against the coronavirus and it is highly sought after.
Following the full approval by the FDA, Moderna will be marketing its COVID-19 vaccine under the brand name ‘Spikevax.’ It now joins Pfizer/BioNTech as the only two licensed vaccines against the coronavirus in the US.
For your daily dose of tech, lifestyle, and trending content, make sure to follow Plat4om on Twitter @Plat4omLive; on Instagram @Plat4om; on LinkedIn at Plat4om, and on Facebook at Plat4om. You can also email us at info@techtalkwithtdafrica.com and join our channel on Telegram at Plat4om. Finally, don’t forget to subscribe to OUR YOUTUBE CHANNEL.